Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Intra-Cellular Therapies Inc. | 23 | 0 | 3 | 0 | €69.00 | €79.43 | 15.115% |
| TG Therapeutics Inc. | 20 | 4 | 3 | 0 | €12.74 | €27.00 | 111.834% |
| MacroGenics Inc. | 11 | 0 | 2 | 0 | €13.61 | €20.00 | 46.951% |
| Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €6.44 | €8.50 | 32.090% |
| ProQR Therapeutics N.V. | 6 | 0 | 1 | 0 | €1.89 | €2.81 | 48.695% |
| Community Health Systems Inc. | 4 | 3 | 1 | 0 | €3.04 | €5.36 | 76.461% |
| XOMA Corp. | 4 | 0 | 1 | 0 | €22.80 | €68.78 | 201.664% |
| Rhythm Pharmaceuticals | 14 | 0 | 1 | 0 | €36.60 | €46.08 | 25.908% |
| X4 Pharmaceuticals, Inc. | 4 | 0 | 1 | 0 | €1.09 | €2.76 | 153.003% |
| Esperion Therapeutis.Inc. | 13 | 0 | 1 | 0 | €1.77 | €8.39 | 373.395% |
| Corcept Therapeutics Inc. | 9 | 0 | 1 | 0 | €21.32 | €33.55 | 57.348% |
| Acorda Therapeutics Cdt | 14 | 0 | 1 | 0 | €0.47 | - | - |
| Insmed Inc. | 13 | 1 | 1 | 0 | €23.20 | €44.01 | 89.684% |
| Akebia Therapeutics Inc. | 8 | 3 | 1 | 0 | €1.25 | €3.60 | 188.389% |
| Krystal Biotech | 16 | 0 | 1 | 0 | €145.15 | €173.22 | 19.338% |
| Heron Therapeutics Inc. | 9 | 1 | 1 | 0 | €2.29 | €4.57 | 99.381% |
| G1 Therapeutics | 13 | 1 | 0 | 0 | €3.60 | €10.05 | 178.968% |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.00 | €19.86 | 231.082% |
| Valneva SE | 2 | 0 | 0 | 0 | €3.51 | €7.00 | 99.544% |
| Innoviva Inc. | 3 | 0 | 0 | 0 | €14.20 | €30.00 | 111.268% |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €6.50 | €8.75 | 34.615% |
| Evolus Inc | 6 | 1 | 0 | 1 | €10.90 | €20.26 | 85.829% |
| Viracta Therapeutics Inc. | 2 | 0 | 0 | 0 | €0.81 | - | - |
| Addus Homecare Corp. | 12 | 1 | 0 | 1 | €87.00 | €97.00 | 11.494% |
| ImmunityBio Inc. | 3 | 0 | 0 | 0 | €6.87 | €10.00 | 45.645% |